


Ask a doctor about a prescription for Theophillinum Tramco
Theophyllinum Tramco 1.2 mg/ml, solution for infusion
Theophyllinum
Theophyllinum Tramco belongs to a group of medicines called xanthines, which relax and dilate the airways in the lungs and make breathing easier.
Theophyllinum Tramco is used to treat symptoms of breathing problems caused by diseases that involve:
Before starting to use Theophyllinum Tramco, discuss it with your doctor or pharmacist:
Your doctor will monitor you during the infusion. The concentration of theophylline in the blood will be controlled.
Do not give this medicine to children under 6 months of age.
Caution is recommended when using in children under 1 year of age.
Caution is recommended when using in patients with liver and/or kidney failure.
Caution is recommended when using in elderly patients.
Tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as any medicines you plan to take, including those available without a prescription.
The action of any of these medicines or Theophyllinum Tramco may be altered, especially if you are taking:
It is recommended not to give this medicine with coffee, tea, chocolate, and paracetamol, as they may cause false results of theophylline concentration test in the blood.
Theophylline may be used during pregnancy only if the doctor considers that the benefit to the mother outweighs the potential risk to the fetus.
Theophylline should not be used in the third trimester of pregnancy, as its administration in the late stages of pregnancy may cause hyperactivity and accelerated heart rate in newborns.
Theophylline should not be used during breastfeeding, as it passes into breast milk and may cause toxic effects in breastfed children.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor before using this medicine.
No effect of theophylline on the ability to drive or use machines is expected.
This medicine contains glucose. If you have been diagnosed with intolerance to some sugars, consult your doctor or pharmacist before taking this medicine.
250 ml of the solution contains 13.5 mg of glucose. This should be taken into account in patients with diabetes.
Theophyllinum Tramco will be administered by a doctor or nurse.
The doctor will decide what dose to use and when to administer it. This depends on the patient's age, weight, clinical condition, and reason for treatment. The dose may also depend on other therapies used at the same time.
Theophylline will be administered by intermittent or continuous, slow intravenous infusion.
The doctor will monitor the concentration of theophylline in the blood.
After the initial dose, a maintenance dose will be administered, depending on the current concentration of theophylline in the blood.
Theophyllinum Tramco will be administered to patients using sterile equipment (so-called infusion set) and aseptic techniques.
If you notice any changes in your well-being after receiving or during the administration of the medicine, inform your doctor or nurse immediately. The doctor may stop the infusion and start appropriate treatment.
If another medicine is added to the Theophyllinum Tramco solution, the symptoms that occur during the infusion may be related to the added medicine.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported for other medicines with a similar composition.
Inform your doctor or nurse immediately if you experience any of the following side effects during or after the administration of the medicine:
The doctor may decide to stop the infusion and start appropriate treatment.
Theophylline side effects most often result from overdose.
In some people, other side effects may occur during the use of Theophyllinum Tramco. If you experience other side effects not listed in this leaflet, inform your doctor.
If you experience any side effects, including those not listed in the leaflet, inform your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Jerozolimskie Avenue 181 C
02-222 Warsaw
Tel.: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Protect from light.
Do not use this medicine after the expiry date stated on the bottle and carton after:
“EXP”. The expiry date refers to the last day of the month.
Do not store or reuse opened packaging.
Do not use this medicine if you notice thatthe solution is not clear or the glass bottle is damaged.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
1 ml of the solution contains 1.2 mg of theophylline.
250 ml of the solution contains 300 mg of theophylline.
This medicine is a clear, colorless solution for infusion in a clear glass bottle with a capacity of 250 ml, closed with a gray rubber stopper and an aluminum cap.
Theophyllinum Tramco, 1.2 mg/ml, solution for infusion is available in cartons containing 20 glass bottles of 250 ml.
Tramco Sp. z o.o.
Wolska Street 14
05-860 Płochocin
[Logo of the marketing authorization holder]
Bieffe Medital S.p.A.
Via Nuova Provinciale
23034 Grosotto (So)
Italy
Information intended for healthcare professionals only:
The total dose should be determined according to the following scheme:
Patients not currently receiving other theophylline preparations:
| Patient groups | Initial dose [mg/kg body weight/hour] | Dose for the first 12 hours [mg/kg body weight/hour] | Maintenance dose for treatment over 12 hours [mg/kg body weight/hour] |
| Children aged 6 months to 9 years Children aged 10 to 16 years and adults who have recently started smoking Non-smoking adults without concomitant diseases Patients with congestive heart failure, liver failure Other patients, including those with right ventricular hypertrophy | 5 5 5 5 5 | 1.0 0.85 0.6 0.4 0.5 | 0.85 0.7 0.43 0.1 0.26 |
Administer immediately after setting up the infusion set.
Additional medicinal products should be introduced through the injection port of the bottle where the infusion device is located.
Shake well.
Follow aseptic procedures.
Do not store solutions to which additional medicinal products have been added.
Medicines for parenteral administration should be visually inspected for particulate matter or color change before administration.
Theophylline should not be administered with infusion fluids containing ascorbic acid, chlorpromazine, codeine, corticotropin, adrenaline, hydralazine, insulin, methadone, methycillin, morphine, noradrenaline, oxytetracycline, papaverine, penicillin G, potassium, phenobarbital sodium, phenytoin, procaine, promazine, promethazine, tetracycline, vitamin B complex with ascorbic acid.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Theophillinum Tramco – subject to medical assessment and local rules.